All stock lists
Sunshine Biopharma Inc. (NASDAQ:SBFM)
US · Delayed Price · Currency is USD
Healthcare · Drug Manufacturers - Specialty & Generic
2.86-0.14 (-4.67%)
Insider Score
––Not scored
SBFM Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
SBFM Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.26 M | 8.09 M | 8.58 M | 9.42 M | 9.41 M | 8.90 M |
| Revenue Growth (YoY) | -1.56 % | -9.13 % | -10.60 % | 11.64 % | 1.15 % | 18.04 % |
| Cost of Revenue | 6.84 M | 5.98 M | 5.65 M | 6.34 M | 5.99 M | 6.17 M |
| Gross Profit | 2.43 M | 2.10 M | 2.93 M | 3.07 M | 3.42 M | 2.73 M |
| SG&A Expense | 3.95 M | 3.34 M | 8.69 M | 3.27 M | 4.03 M | 3.64 M |
| R&D Expense | 13.22 K | 31.72 K | -530.81 K | 119.30 K | 196.23 K | 215.28 K |
| Operating Expenses | 4.04 M | 3.50 M | 4.59 M | 3.61 M | 4.42 M | 4.03 M |
| Operating Income | -1.61 M | -1.40 M | -1.66 M | -531.96 K | -992.85 K | -1.30 M |
| Pretax Income | -1.56 M | -1.24 M | -1.73 M | -1.02 M | -1.98 M | -1.22 M |
| Tax Provision | 0.00 | 0.00 | 408.37 K | -137.44 K | -209.17 K | -40.16 K |
| Net Income | -1.56 M | -1.24 M | -2.14 M | -883.82 K | -1.77 M | -1.18 M |
| EPS (Basic) | -23.00 | -50.00 | -92.00 | -38.00 | -1560.00 | -88.00 |
| EPS (Diluted) | -23.00 | -50.00 | -92.00 | -38.00 | -1560.00 | -88.00 |
| Shares Outstanding | 68.27 K | 24.53 K | 20.79 K | 23.26 K | 1.12 K | 13.52 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.